The European Medicines Agency has indicated tighter oversight of sterile injectable manufacturing, with expanded audits planned for fill-finish sites linked to hospital supply contracts.
Contract manufacturers are updating quality agreements and batch-release documentation ahead of the next inspection cycle.
